Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]
El Hindi T., Anugulruengkitt S., Lapphra K., Limkittikul K., Tangsathapornpong A., Galindo C.M., Hellwig M., Roubinis N., Schuring R., Biswal S., Folschweiller N. Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]. Vaccine (2025). doi:10.1016/j.vaccine.2025.127785 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112626
Title
Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]
